{"id":102,"date":"2012-04-12T12:03:39","date_gmt":"2012-04-12T12:03:39","guid":{"rendered":"http:\/\/people.unica.it\/basecds\/?page_id=102"},"modified":"2014-05-13T09:55:50","modified_gmt":"2014-05-13T07:55:50","slug":"home","status":"publish","type":"page","link":"https:\/\/sites.unica.it\/metabolomicaclinica\/","title":{"rendered":"Home"},"content":{"rendered":"<p><strong>Metabolomics @ UniCa<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #000000\">Since 2008, metabolomics (one of the youngest \u201c-omics\u201d) has been the major interest of the group. Carrying out metabolomic analyses, and collaborating with different clinicians such as neonatologists, neurologists, cardiologists, oncologists, forensic doctors, we are trying to better understand the metabolic changes in biofluids and tissues for identifying new biomarkers of diseases, predict the prognosis and the response to the therapy. A better understanding of the role of metabolites changes in physiophatological conditions might lead to a new tailored medicine. <\/span><\/p>\n<p><span style=\"color: #000000\">Main pathological conditions under investigations are: neonatal hypoxia, multiple sclerosis, epilepsy, amyotrophic lateral sclerosis, heart failure, time from death, cancer, chronic inflammatory bowel disease. To address these, we are developing analytical chemistry techniques, by using\u00a0 NMR spectroscopy and mass spectrometry, and innovative statistical approaches. <\/span><\/p>\n<p><span style=\"color: #000000\">The working environment includes medical doctors, biologists, chemists, pharmaceutical chemists and mathematicians. <\/span><\/p>\n<p><span style=\"color: #000000\">The Metabolomics Group is also involved in the designing of database tools for metabolomics.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Metabolomics @ UniCa &nbsp; Since 2008, metabolomics (one of the youngest \u201c-omics\u201d) has been the major interest of the group. Carrying out metabolomic analyses, and collaborating with different clinicians such as neonatologists, neurologists, cardiologists, oncologists, forensic doctors, we are trying to better understand the metabolic changes in biofluids and tissues for identifying new biomarkers of diseases, predict the prognosis and the response to the therapy. A better understanding of the role of metabolites changes in physiophatological conditions might lead to a new tailored medicine. Main pathological conditions under investigations are: neonatal hypoxia, multiple sclerosis, epilepsy, amyotrophic lateral sclerosis, heart failure, <a href='https:\/\/sites.unica.it\/metabolomicaclinica\/' class='excerpt-more'>[&#8230;]<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-102","page","type-page","status-publish","hentry","post-seq-1","post-parity-odd","meta-position-corners","fix"],"_links":{"self":[{"href":"https:\/\/sites.unica.it\/metabolomicaclinica\/wp-json\/wp\/v2\/pages\/102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.unica.it\/metabolomicaclinica\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.unica.it\/metabolomicaclinica\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.unica.it\/metabolomicaclinica\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.unica.it\/metabolomicaclinica\/wp-json\/wp\/v2\/comments?post=102"}],"version-history":[{"count":18,"href":"https:\/\/sites.unica.it\/metabolomicaclinica\/wp-json\/wp\/v2\/pages\/102\/revisions"}],"predecessor-version":[{"id":1741,"href":"https:\/\/sites.unica.it\/metabolomicaclinica\/wp-json\/wp\/v2\/pages\/102\/revisions\/1741"}],"wp:attachment":[{"href":"https:\/\/sites.unica.it\/metabolomicaclinica\/wp-json\/wp\/v2\/media?parent=102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}